OptimizeRx Corp (OPRX) › RevenueOptimizeRx Corp (OPRX) — RevenueAnnual figures by fiscal year, from SEC filings.2010: $71.1K2011: $1.11M2012: $1.99M2013: $4.68M2014: $6.50M2015: $7.22M2016: $7.75M2017: $12.13M2018: $21.21M2019: $24.60M2020: $43.31M2021: $61.29M2022: $62.45M2023: $71.52M2024: $92.13M2025: $109.43M$109.43M2010Revenue (USD)2025Fiscal YearRevenueChange YoY2025$109.43M+18.8%2024$92.13M+28.8%2023$71.52M+14.5%2022$62.45M+1.9%2021$61.29M+41.5%2020$43.31M+76.1%2019$24.60M+16.0%2018$21.21M+74.9%2017$12.13M+56.5%2016$7.75M+7.4%2015$7.22M+11.0%2014$6.50M+39.0%2013$4.68M+135.3%2012$1.99M+79.0%2011$1.11M+1464.1%2010$71.1K—Other metrics: Cost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share